• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LI-RADS v2018 对钆塞酸增强磁共振成像鉴别静脉内肿瘤与单纯性血栓的观察者间一致性和准确性。

Inter-observer agreement and accuracy of LI-RADS v2018 for differentiating tumor in vein from bland thrombus using gadoxetic acid-enhanced magnetic resonance imaging.

机构信息

Department of Radiology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan.

Department of Radiology, University of Yamanashi, Chuo, Yamanashi, Japan.

出版信息

Abdom Radiol (NY). 2023 Aug;48(8):2557-2569. doi: 10.1007/s00261-023-03964-4. Epub 2023 May 29.

DOI:10.1007/s00261-023-03964-4
PMID:37246973
Abstract

PURPOSE

To assess inter-observer agreement and accuracy of LI-RADS v2018 for differentiating tumor in vein (TIV) from bland thrombus on gadoxetic acid-enhanced magnetic resonance imaging (Gx-MRI). Secondarily, to determine whether a multi-feature model improves accuracy compared to LI-RADS.

METHODS

We retrospectively identified consecutive patients at risk for hepatocellular carcinoma with venous occlusion(s) reported on Gx-MRI. Five radiologists independently classified each occlusion as TIV or bland thrombus using the LI-RADS TIV criterion (enhancing soft tissue in vein). They also evaluated imaging features suggestive of TIV or bland thrombus. Intra-class correlation coefficient (ICC) was calculated for individual features. A multi-feature model was developed based on consensus scores of features with > 5% consensus prevalence and > 0.40 ICC. Sensitivity and specificity of the LI-RADS criterion and of the cross-validated multi-feature model were compared.

RESULTS

Ninety-eight patients with 103 venous occlusions (58 TIV, 45 bland thrombus) were included. The LI-RADS criterion provided 0.63 ICC and, depending on the reader, 0.62-0.93 sensitivity and 0.87-1.00 specificity. Five other features had > 5% consensus prevalence and > 0.40 ICC, including three LI-RADS suggestive features and two non-LI-RADS features. The optimal multi-feature model incorporated the LI-RADS criterion and one LI-RADS suggestive feature (occluded or obscured vein contiguous with malignant parenchymal mass). After cross-validation, the multi-feature model did not improve sensitivity or specificity compared to the LI-RADS criterion (P = 0.23 and 0.25, respectively).

CONCLUSION

Using Gx-MRI, the LI-RADS criterion for TIV provides substantial inter-observer agreement, variable sensitivity, and high specificity for differentiating TIV from bland thrombus. A cross-validated multi-feature model did not improve diagnostic performance.

摘要

目的

评估 LI-RADS v2018 区分钆塞酸增强磁共振成像(Gx-MRI)中肿瘤在静脉内(TIV)与单纯性血栓的观察者间一致性和准确性。其次,确定多特征模型是否比 LI-RADS 提高准确性。

方法

我们回顾性地在 Gx-MRI 上识别出有静脉闭塞报道的肝细胞癌高危患者。五位放射科医生使用 LI-RADS TIV 标准(静脉内强化软组织)独立对每个闭塞进行分类,将其分为 TIV 或单纯性血栓。他们还评估了提示 TIV 或单纯性血栓的影像学特征。计算个体特征的组内相关系数(ICC)。基于>5%共识患病率和>0.40 ICC 的特征共识评分,建立多特征模型。比较 LI-RADS 标准和交叉验证多特征模型的敏感性和特异性。

结果

共纳入 98 例患者,103 个静脉闭塞(58 个 TIV,45 个单纯性血栓)。LI-RADS 标准提供 0.63 ICC,根据观察者的不同,敏感性为 0.62-0.93,特异性为 0.87-1.00。其他五个特征的共识患病率>5%,ICC>0.40,包括三个 LI-RADS 提示特征和两个非 LI-RADS 特征。最优多特征模型纳入 LI-RADS 标准和一个 LI-RADS 提示特征(与恶性实质肿块连续的闭塞或模糊静脉)。交叉验证后,与 LI-RADS 标准相比,多特征模型并未提高敏感性或特异性(P=0.23 和 0.25)。

结论

使用 Gx-MRI,LI-RADS 标准对于 TIV 的区分具有良好的观察者间一致性、可变的敏感性和高特异性。交叉验证的多特征模型并未提高诊断性能。

相似文献

1
Inter-observer agreement and accuracy of LI-RADS v2018 for differentiating tumor in vein from bland thrombus using gadoxetic acid-enhanced magnetic resonance imaging.LI-RADS v2018 对钆塞酸增强磁共振成像鉴别静脉内肿瘤与单纯性血栓的观察者间一致性和准确性。
Abdom Radiol (NY). 2023 Aug;48(8):2557-2569. doi: 10.1007/s00261-023-03964-4. Epub 2023 May 29.
2
Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?肝细胞癌:钆塞酸增强磁共振和弥散加权成像的 LI-RADS v2017 能否提高诊断准确性?
World J Gastroenterol. 2019 Feb 7;25(5):622-631. doi: 10.3748/wjg.v25.i5.622.
3
Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI?改良版 LI-RADS 是否能提高 LI-RADS v2018 对钆塞酸增强 MRI 诊断 10-19mm 肝细胞癌的敏感性?
Abdom Radiol (NY). 2022 Feb;47(2):596-607. doi: 10.1007/s00261-021-03339-7. Epub 2021 Nov 13.
4
Tumor in vein (LR-TIV) and liver imaging reporting and data system (LI-RADS) v2018: diagnostic features, pitfalls, prognostic and management implications.静脉内肿瘤(LR-TIV)和肝脏成像报告和数据系统(LI-RADS)v2018:诊断特征、陷阱、预后和管理意义。
Abdom Radiol (NY). 2021 Dec;46(12):5723-5734. doi: 10.1007/s00261-021-03270-x. Epub 2021 Sep 14.
5
Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.LI-RADS 版本 2018、LI-RADS 版本 2017 和 OPTN 标准用于诊断肝细胞癌的性能比较。
AJR Am J Roentgenol. 2020 Nov;215(5):1085-1092. doi: 10.2214/AJR.20.22772. Epub 2020 Sep 2.
6
Suboptimal performance of LI-RADS v2018 on gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates.LI-RADS v2018 对钆塞酸增强 MRI 检测肝移植候选者肝细胞癌的性能不佳。
Eur Radiol. 2024 Jan;34(1):465-474. doi: 10.1007/s00330-023-10014-6. Epub 2023 Aug 3.
7
Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS.LI-RADS 修订版:用于诊断肝细胞癌的钆塞酸增强磁共振成像最佳词汇
Abdom Radiol (NY). 2019 Sep;44(9):3078-3088. doi: 10.1007/s00261-019-02077-1.
8
Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.对比增强超声与对比增强磁共振成像在肝脏影像报告与数据系统诊断局灶性肝脏病变中的比较。
Ultrasound Med Biol. 2020 May;46(5):1216-1223. doi: 10.1016/j.ultrasmedbio.2020.01.023. Epub 2020 Feb 27.
9
The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.钆贝葡胺增强肝胆期 MRI 病变低信号强度在 LI-RADS v2018 标准中作为 HCC 分类的另一个主要影像学特征的作用。
Eur Radiol. 2021 Oct;31(10):7715-7724. doi: 10.1007/s00330-021-07807-y. Epub 2021 Mar 29.
10
Increasing the sensitivity of LI-RADS v2018 for diagnosis of small (10-19 mm) HCC on extracellular contrast-enhanced MRI.提高 LI-RADS v2018 对细胞外对比增强 MRI 中小肝癌(10-19mm)诊断的灵敏度。
Abdom Radiol (NY). 2021 Apr;46(4):1530-1542. doi: 10.1007/s00261-020-02790-2. Epub 2020 Oct 11.

引用本文的文献

1
Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment.肝细胞癌血管生成的研究进展:对诊断、预后和治疗的影响。
Korean J Radiol. 2024 Oct;25(10):887-901. doi: 10.3348/kjr.2024.0307.

本文引用的文献

1
LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.CT 和肝胆 MRI 中的 LI-RADS 肿瘤在静脉内。
Radiology. 2022 Jan;302(1):107-115. doi: 10.1148/radiol.2021210215. Epub 2021 Sep 28.
2
Tumor in vein (LR-TIV) and liver imaging reporting and data system (LI-RADS) v2018: diagnostic features, pitfalls, prognostic and management implications.静脉内肿瘤(LR-TIV)和肝脏成像报告和数据系统(LI-RADS)v2018:诊断特征、陷阱、预后和管理意义。
Abdom Radiol (NY). 2021 Dec;46(12):5723-5734. doi: 10.1007/s00261-021-03270-x. Epub 2021 Sep 14.
3
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance.
肝细胞癌患者肝静脉肿瘤血栓:发生率和临床意义。
United European Gastroenterol J. 2021 Jun;9(5):590-597. doi: 10.1002/ueg2.12098. Epub 2021 Jun 2.
4
LI-RADS Major Features on MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.LI-RADS 磁共振成像诊断肝细胞癌的主要特征:系统评价和荟萃分析。
J Magn Reson Imaging. 2021 Aug;54(2):518-525. doi: 10.1002/jmri.27570. Epub 2021 Feb 27.
5
The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis.肝脏影像报告和数据系统静脉内肿瘤分类:系统评价和荟萃分析。
Eur Radiol. 2021 Apr;31(4):2497-2506. doi: 10.1007/s00330-020-07282-x. Epub 2020 Oct 1.
6
How to Best Detect Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Meeting the Milan Criteria: Gadoxetic Acid-Enhanced MRI versus Contrast-Enhanced CT.如何最佳检测符合米兰标准的肝细胞癌患者的门静脉肿瘤血栓形成:钆塞酸二钠增强磁共振成像与对比增强计算机断层扫描的比较
Liver Cancer. 2020 Jun;9(3):293-307. doi: 10.1159/000505191. Epub 2020 Jan 28.
7
Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.超声造影在肝癌患者门静脉血栓与癌栓鉴别诊断中的应用:系统评价和荟萃分析。
Eur Radiol. 2020 May;30(5):2871-2880. doi: 10.1007/s00330-019-06649-z. Epub 2020 Feb 4.
8
Interobserver Agreement of Magnetic Resonance Imaging of Liver Imaging Reporting and Data System Version 2018.肝脏影像报告和数据系统(LI-RADS)2018版磁共振成像的观察者间一致性
J Comput Assist Tomogr. 2020 Jan/Feb;44(1):118-123. doi: 10.1097/RCT.0000000000000945.
9
Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.肝硬化与非肝硬化患者门静脉血栓形成的诊断、发展和治疗。
Gastroenterology. 2019 May;156(6):1582-1599.e1. doi: 10.1053/j.gastro.2019.01.265. Epub 2019 Feb 13.
10
Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.鉴别肝癌肝移植候选者肿瘤与非肿瘤性门静脉血栓:A-VENA 标准。
Liver Transpl. 2019 Feb;25(2):207-216. doi: 10.1002/lt.25345.